Net Impact (CE) (USOTC:NTHD)
Historical Stock Chart
From Jan 2020 to Jan 2025
NetImpact Courts World Healthcare Leaders; Plans to Meet with Senior Decision
and Policy Makers, Analysts and Academics at International Health Summit
LAS VEGAS, Nov. 13 /PRNewswire-FirstCall/ -- NetImpact Holdings, Inc. (OTC Pink
Sheets: NTHD) announced today that they plan to meet with senior decision and
health policy makers, analysts and leading academics at the upcoming
International Health Summit. Over 500 health sector leaders from 50 countries
will gather for networking opportunities in Hollywood, FL December 7-10 at the
8th Annual International Health Summit. NetImpact expects to schedule interviews
with influential leaders in the international healthcare market and identify
ways of working together.
NetImpact will host a cocktail reception on Monday evening, December 8, allowing
the delegates to personally meet with Dr. Scott Optenberg, NetImpact's Executive
Vice President of Medical Information Systems, and President of NetImpact's
Healthcare Services Group. Dr. Optenberg will explain the integral role that
NetImpact's products play when NetImpact is called upon to build/rebuild
healthcare infrastructures in organizations, institutions, and countries.
The reception will follow a joint address by Dr. Optenberg and Dr. Mamadou S.
Traore, Director, Agency of Hospitals Assessment and Planning, Ministry of
Health, Republic of Mali. Their session is titled: "IT Innovations: Enhancing
Access in Remote Areas with New Medical and IT Technologies: Mali Case Study"
and will specifically examine NetImpact's upcoming assessment of the healthcare
infrastructure in Mali.
About NetImpact Products
-- NetCare7.0(TM) -- a medical information collection, management and analysis
suite of software offered exclusively by NetImpact, which is expected to meet
current and future healthcare needs.
-- MDS 200 -- a self-contained medical laboratory the size of a small suitcase
that automatically processes human fluid samples for early disease detection and
treatment.
-- NWT 4000 -- a device the size of a handheld radio that reduces chronic pain
related to withdrawal from drugs, opiates, tobacco and alcohol.
About NetImpact
NetImpact Holdings, Inc. is a technology-to-market company focusing on the
installation, restructuring and management of global healthcare and medical
delivery systems. Through acquisitions and extensive access to
international/U.S. distribution networks, NetImpact specializes in presenting
technology that will assist in the improvement of productivity, applications
development and technology transfer in developing countries.
http://www.netimpact.com/
Safe Harbor Statement
The statements in this release that are not historical facts are forward-
looking statements within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934. NetImpact Holdings,
Inc. intends that such forward-looking statements be subject to the safe harbors
created thereby. These forward-looking statements include predictions, estimates
and other statements that involve a number of risks and uncertainties any, or
all, of which could cause actual results to differ materially from any future
performance suggested herein. While this outlook represents NetImpact Holdings,
Inc.'s current judgment on the future direction of the business, such risks and
uncertainties may individually, or mutually, impact the matters herein
described, including but not limited to product acceptance, the economy,
competition, governmental actions, results of litigation, technological and/or
other factors, which are outside the control of NetImpact Holdings, Inc. as well
as those risks and uncertainties detailed in the Company's Security and Exchange
Commission filings.
CONTACT
Jerry Jennings
Emerson Gerard Associates
561-881-7318
DATASOURCE: NetImpact Holdings, Inc.
CONTACT: Jerry Jennings of Emerson Gerard Associates, +1-561-881-7318, or
email, , for NetImpact
Web site: http://www.netimpact.com/